Long Read Sequencing Market Size, Share & Trends Analysis Distribution by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, Single-molecule real-time sequencing, Synthetic long-read sequencing), Application, Usage, End Users and Segment Forecasts, 2023-2031

Report Id: 2694 Pages: 168 Last Updated: 19 August 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Long Read Sequencing Market -

Long Read Sequencing Market by Offerings -

  • Consumables
  • Instruments
  • Services

long read sequencing

Long Read Sequencing Market by Technology -

  • Nanopore sequencing
  • Single-molecule real-time sequencing
  • Synthetic long-read sequencing

 Long Read Sequencing Market by Workflow -

  • Sequencing
  • Sample Preparation
  • Data analysis

Long Read Sequencing Market by Application -

  • Whole Genome Sequencing
  • Targeted Sequencing
  • Metagenomics
  • Epigenetics
  • Whole exome sequencing
  • Other applications

Long Read Sequencing Market by Usage -

  • Research
  • Clinical

Long Read Sequencing Market by End Users -

  • Academic & Research Institutes
  • Hospitals, Clinics & Diagnostic Labs
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Long Read Sequencing Market by Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Long Read Sequencing Market Snapshot

Chapter 4. Global Long Read Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Offerings Estimates & Trend Analysis
5.1. by Offerings & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Offerings:

5.2.1. Consumables
5.2.2. Instruments
5.2.3. Services

Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:

6.2.1. Nanopore sequencing
6.2.2. Single-molecule real-time sequencing
6.2.3. Synthetic long-read sequencing

Chapter 7. Market Segmentation 3: by Workflow Estimates & Trend Analysis
7.1. by Workflow & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Workflow:

7.2.1. Sequencing
7.2.2. Sample Preparation
7.2.3. Data analysis

Chapter 8. Market Segmentation 4: by Application Estimates & Trend Analysis
8.1. by Application & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

8.2.1. Whole Genome Sequencing
8.2.2. Targeted Sequencing
8.2.3. Metagenomics
8.2.4. Epigenetics
8.2.5. Whole exome sequencing
8.2.6. Other applications

Chapter 9. Market Segmentation 5: by Usage Estimates & Trend Analysis
9.1. by Usage & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Usage:
9.2.1. Research
9.2.2. Clinical

Chapter 10. Market Segmentation 6: by End Users Estimates & Trend Analysis
10.1. by End Users & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End Users:

10.2.1. Academic & Research Institutes
10.2.2. Hospitals, Clinics & Diagnostic Labs
10.2.3. Pharmaceutical & Biotechnology Companies
10.2.4. Other End Users

Chapter 11. Long Read Sequencing Market Segmentation 7: Regional Estimates & Trend Analysis

11.1. North America
11.1.1. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.1.2. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.1.3. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.1.4. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.1.5. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.1.6. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.1.7. North America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.2. Europe
11.2.1. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.2.2. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.2.3. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.2.4. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.2.5. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.2.6. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.2.7. Europe Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.3. Asia Pacific
11.3.1. Asia Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.3.2. Asia Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.3.3. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.3.4. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.3.5. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.3.6. Asia-Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.3.7. Asia Pacific Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.4. Latin America
11.4.1. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.4.2. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.4.3. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.4.4. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.4.5. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.4.6. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.4.7. Latin America Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

11.5. Middle East & Africa
11.5.1. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2024-2031
11.5.2. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
11.5.3. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Workflow, 2024-2031
11.5.4. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.5.5. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Usage, 2024-2031
11.5.6. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
11.5.7. Middle East & Africa Long Read Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles

12.2.1. 10X Genomics, Inc.
12.2.2. Agilent Technologies, Inc.
12.2.3. Azenta US, Inc.
12.2.4. BaseClear BV
12.2.5. BGI Group
12.2.6. CD Genomics
12.2.7. Danaher Corporation
12.2.8. EdenRoc Sciences
12.2.9. Element Biosciences
12.2.10. Grandomics
12.2.11. Illumina, Inc.
12.2.12. New England Biolabs
12.2.13. Novogene Co., Ltd.
12.2.14. Oxford Nanopore Technologies plc.
12.2.15. PacBio
12.2.16. QIAGEN
12.2.17. Revvity, Inc.
12.2.18. Sage Sciences, Inc.
12.2.19. Takara Bio Inc.
12.2.20. Thermo Fisher Scientific Inc.
12.2.21. Cantata Bio
12.2.22. FG Technologies
12.2.23. GrandOmics
12.2.24. MicrobesNG
12.2.25. St Vincents Hospital Melbourne
12.2.26. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1630
Security Code field cannot be blank!

Frequently Asked Questions

The Long Read Sequencing Market Size is valued at USD 594.8 Mn in 2023 and is predicted to reach USD 4,571.3 Mn by the year 2031

The Long Read Sequencing Market is expected to grow at an 29.7% CAGR during the forecast period for 2024-2031.

10X Genomics, Inc., Agilent Technologies, Inc., Azenta US, Inc. , BaseClear BV, BGI Group, CD Genomics, Danaher Corporation, EdenRoc Sciences, Element

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying